Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH.

JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758. Review.

2.

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH.

Drugs. 2010 Mar 26;70(5):605-21. doi: 10.2165/10898530-000000000-00000. Review.

3.
4.

Brand name versus generic warfarin: a systematic review of the literature.

Dentali F, Donadini MP, Clark N, Crowther MA, Garcia D, Hylek E, Witt DM, Ageno W; Warfarin Associated Research Projects and Other Endeavors (WARPED) Consortium.

Pharmacotherapy. 2011 Apr;31(4):386-93. doi: 10.1592/phco.31.4.386. Review.

PMID:
21449627
5.

Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review.

van der Meersch A, Dechartres A, Ravaud P.

PLoS One. 2011;6(8):e23611. doi: 10.1371/journal.pone.0023611. Epub 2011 Aug 17. Review.

6.

Equivalence of generic and brand-name drugs for cardiovascular disease.

Carter BL.

JAMA. 2009 Apr 22;301(16):1654; author reply 1655-6. doi: 10.1001/jama.2009.520. No abstract available.

PMID:
19383950
7.

Equivalence of generic and brand-name drugs for cardiovascular disease.

Zema MJ.

JAMA. 2009 Apr 22;301(16):1654-5; author reply 1655-6. doi: 10.1001/jama.2009.521. No abstract available.

PMID:
19383949
8.

Generic versus brand-name drugs used in cardiovascular diseases.

Manzoli L, Flacco ME, Boccia S, D'Andrea E, Panic N, Marzuillo C, Siliquini R, Ricciardi W, Villari P, Ioannidis JP.

Eur J Epidemiol. 2016 Apr;31(4):351-68. doi: 10.1007/s10654-015-0104-8. Epub 2015 Nov 30. Review.

9.

Equivalence of generic and brand-name drugs for cardiovascular disease.

Reiffel JA.

JAMA. 2009 Apr 22;301(16):1655; author reply 1655-6. doi: 10.1001/jama.2009.522. No abstract available.

PMID:
19383951
10.

Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study.

Corrao G, Soranna D, Merlino L, Mancia G.

Eur J Clin Invest. 2014 Oct;44(10):933-9. doi: 10.1111/eci.12326.

PMID:
25132063
11.
12.

Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.

Corrao G, Soranna D, Arfè A, Casula M, Tragni E, Merlino L, Mancia G, Catapano AL.

Eur J Intern Med. 2014 Oct;25(8):745-50. doi: 10.1016/j.ejim.2014.08.002. Epub 2014 Sep 6.

PMID:
25200803
13.

Meta-analysis for bioequivalence review.

Chow SC, Liu J.

J Biopharm Stat. 1997 Mar;7(1):97-111.

PMID:
9056591
14.

[Bioequivalence and generics of index drugs with narrow therapeutic margins].

Le Corre P.

Presse Med. 2010 Feb;39(2):169-76. doi: 10.1016/j.lpm.2009.09.017. Epub 2009 Nov 22. French.

PMID:
19932591
15.

Rational use of generic psychotropic drugs.

Carbon M, Correll CU.

CNS Drugs. 2013 May;27(5):353-65. doi: 10.1007/s40263-013-0045-2. Review.

PMID:
23620145
17.

Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.

Pereira JA, Holbrook AM, Dolovich L, Goldsmith C, Thabane L, Douketis JD, Crowther M, Bates SM, Ginsberg JS.

Can J Clin Pharmacol. 2005 Fall;12(3):e229-39. Epub 2005 Oct 24.

18.

Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.

Spence MM, Nguyen LM, Hui RL, Chan J.

Pharmacotherapy. 2012 Nov;32(11):981-7. doi: 10.1002/phar.1130. Epub 2012 Oct 16.

PMID:
23074134
19.

News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names.

Hochman M, Hochman S, Bor D, McCormick D.

JAMA. 2008 Oct 1;300(13):1544-50. doi: 10.1001/jama.300.13.1544.

PMID:
18827211
20.

Generic drugs in dermatology: part II.

Payette M, Grant-Kels JM.

J Am Acad Dermatol. 2012 Mar;66(3):353.e1-15; quiz 367-8. doi: 10.1016/j.jaad.2011.11.945. Review.

PMID:
22342022
Items per page

Supplemental Content

Write to the Help Desk